Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.

TECH

Bio Techne (TECH)

Bio Techne Corporation
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:TECH
DateHeureSourceTitreSymboleSociété
27/11/202413h00PR Newswire (US)BIO-TECHNE TO PRESENT AT THE CITI 2024 GLOBAL HEALTHCARE CONFERENCENASDAQ:TECHBio Techne Corporation
25/11/202415h02PR Newswire (US)Gemini Bioproducts, LLC Acquires Selected Fetal Bovine Serum (FBS) Product Rights and Inventory from Bio-TechneNASDAQ:TECHBio Techne Corporation
20/11/202413h00PR Newswire (US)BIO-TECHNE ANNOUNCES NEW DISTRIBUTION AGREEMENT WITH LEADER LIFE SCIENCESNASDAQ:TECHBio Techne Corporation
14/11/202413h00PR Newswire (US)BIO-TECHNE TO HIGHLIGHT NOVEL SOLUTIONS FOR CANCER AND CARRIER SCREENING AT AMP 2024 ANNUAL MEETING & EXPONASDAQ:TECHBio Techne Corporation
11/11/202423h47PR Newswire (US)UPDATED: BIO-TECHNE ANNOUNCES IVDR CERTIFIED HEMATOLOGY CONTROLS AND CALIBRATORSNASDAQ:TECHBio Techne Corporation
11/11/202413h00PR Newswire (US)BIO-TECHNE ANNOUNCES IVDR CERTIFIED HEMATOLOGY CONTROLS AND CALIBRATORSNASDAQ:TECHBio Techne Corporation
08/11/202423h31Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:TECHBio Techne Corporation
08/11/202413h00PR Newswire (US)BIO-TECHNE TO PRESENT AT INVESTOR CONFERENCESNASDAQ:TECHBio Techne Corporation
07/11/202413h00PR Newswire (US)ScaleReady Announces multiple G-Rex® Grants have been awarded to leading investigators at the Baylor College of Medicine's Center for Cell and Gene TherapyNASDAQ:TECHBio Techne Corporation
06/11/202413h00PR Newswire (US)BIO-TECHNE TO PRESENT AT THE SOCIETY FOR IMMUNOTHERAPY OF CANCER (SITC) 39TH ANNUAL MEETINGNASDAQ:TECHBio Techne Corporation
05/11/202422h48Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TECHBio Techne Corporation
05/11/202422h33Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TECHBio Techne Corporation
05/11/202422h31Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:TECHBio Techne Corporation
05/11/202413h00PR Newswire (US)LUNAPHORE COMET™ PLATFORM PAVES THE WAY FOR SPATIAL BIOLOGY ADOPTION IN CLINICAL RESEARCHNASDAQ:TECHBio Techne Corporation
30/10/202411h30PR Newswire (US)BIO-TECHNE DECLARES DIVIDENDNASDAQ:TECHBio Techne Corporation
30/10/202411h30PR Newswire (US)BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2025 RESULTSNASDAQ:TECHBio Techne Corporation
29/10/202412h00PR Newswire (US)ScaleReady Announces a G-Rex® Grant has been awarded to Luminary TherapeuticsNASDAQ:TECHBio Techne Corporation
10/10/202413h00PR Newswire (US)BIO-TECHNE TO HOST CONFERENCE CALL ON OCTOBER 30, 2024, TO ANNOUNCE FIRST QUARTER FISCAL 2025 FINANCIAL RESULTSNASDAQ:TECHBio Techne Corporation
09/10/202413h00PR Newswire (US)ScaleReady announces a G-Rex® Grant has been awarded to LIfT BiosciencesNASDAQ:TECHBio Techne Corporation
08/10/202413h00PR Newswire (US)ScaleReady announces a G-Rex® Grant has been awarded to Dr. Eric Tran of the Earle A. Chiles Research Institute, a division of Providence Cancer InstituteNASDAQ:TECHBio Techne Corporation
07/10/202413h00PR Newswire (US)ScaleReady announces a G-Rex® Grant has been awarded to renowned cancer immunologist Dr. Christopher A. KlebanoffNASDAQ:TECHBio Techne Corporation
26/09/202413h00PR Newswire (US)LUNAPHORE PARTNERS WITH DISCOVERY LIFE SCIENCES TO BRING INNOVATIVE SPATIAL BIOLOGY SOLUTIONS TO CLINICAL RESEARCHNASDAQ:TECHBio Techne Corporation
24/09/202413h00PR Newswire (US)BIO-TECHNE TO PRESENT AT NEUROSCIENCE 2024-THE SOCIETY FOR NEUROSCIENCE (SfN) ANNUAL MEETINGNASDAQ:TECHBio Techne Corporation
18/09/202413h00PR Newswire (US)BIO-TECHNE ISSUES 2024 CORPORATE SUSTAINABILITY REPORTNASDAQ:TECHBio Techne Corporation
18/09/202413h00PR Newswire (US)ScaleReady announces a G-Rex® Grant has been awarded to ImmunoScapeNASDAQ:TECHBio Techne Corporation
17/09/202413h00PR Newswire (US)ScaleReady announces a G-Rex® Grant has been awarded to Verismo TherapeuticsNASDAQ:TECHBio Techne Corporation
17/09/202413h00PR Newswire (US)Verismo Therapeutics Awarded a ScaleReady™ G-Rex® GrantNASDAQ:TECHBio Techne Corporation
16/09/202413h00PR Newswire (US)ScaleReady and Bio-Techne Announce Optimal Closed System Cytokine Packaged for Single Step Use in Closed System G-Rex® Manufacture of CAR-T and TCR TherapiesNASDAQ:TECHBio Techne Corporation
12/09/202413h04Edgar (US Regulatory)Form ARS - Annual Report to Security HoldersNASDAQ:TECHBio Techne Corporation
12/09/202413h02Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:TECHBio Techne Corporation
 Showing the most relevant articles for your search:NASDAQ:TECH